Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Development of a nalmefene formulation suitable for a community-use auto-injector.
Journal: British journal of clinical pharmacology
Published: January 14, 2026
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Interactions Between Alcohol and Sunobinop in Healthy Participants.
Journal: Journal of clinical psychopharmacology
Published: October 13, 2025
Human Abuse Potential of Single Oral Doses of Sunobinop, a Novel, Highly Potent, and Selective Partial Agonist for Nociceptin/Orphanin-FQ Peptide (NOP) Receptors.
Journal: Journal of clinical psychopharmacology
Published: September 10, 2025
Reversal of Fentanyl-Induced Respiratory Depression in Healthy Subjects by Intramuscular Nalmefene Administered by Auto-Injector Versus Intranasal Naloxone.
Journal: Journal of clinical pharmacology
Published: April 17, 2025
Evaluation of sunobinop for next-day residual effects in healthy participants.
Journal: Frontiers in pharmacology
Published: May 14, 2024
Time Course of Reversal of Fentanyl-Induced Respiratory Depression in Healthy Subjects by Intramuscular Nalmefene and Intramuscular and Intranasal Naloxone.
Journal: Journal of clinical pharmacology
Published: March 08, 2024
Pharmacokinetics and Tolerability of the Cancer-Targeting MRI Contrast Agent MT218 in Healthy Males.
Pharmacokinetics and Tolerability of the Cancer-Targeting MRI Contrast Agent MT218 in Healthy Males.
Journal: Investigative radiology
Published: November 28, 2023
The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users.
Journal: Translational psychiatry
Published: March 14, 2023
Establishing a clinical pharmacology fellowship program for physicians, pharmacists, and pharmacologists: a newly accredited interdisciplinary training program at the Ohio State University.
Journal: Advances in medical education and practice
Published: July 15, 2014
Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studies.
Journal: PloS one
Published: November 22, 2013
Reliability of professional volunteers recruited for clinical trials.
Journal: Journal of clinical pharmacology
Published: October 18, 2013
An Open-Label Randomized Crossover Trial of Lyophilized Black Raspberries on Postprandial Inflammation in Older Overweight Males: A Pilot Study.
Journal: American journal of therapeutics
Published: August 29, 2013
Last Updated: 09/26/2026